1953 Fitzgerald Report

The 1953 Fitzgerald Report was a highly controversial and suppressed document from 1953, written by Special Counsel for the Senate Interstate and Foreign Commerce Committee member Benedict Fitzgerald. His report would reveal a monopolistic effort on behalf of many organizations to block effective cancer treatments.
Commissioned by Congressman Charles Tobey in the 1950s to investigate a possible conspiracy in orthodox medicine at the time, Benedict Fitzgerald conducted an extensive study on the practices of many establishments specializing in cancer issues. These included:
* American Cancer Society
* American Medical Association
* Anne Fuller Fund, New Haven, Connecticut
* Babe Ruth Foundation
* Black, Stevenson Cancer Foundation, Hattiesburg, Mississippi
* Bondy Fund, New York
* Jonathan Bowman Fund, Madison, Wisconsin
* Crocker Cancer Research Fund, New York
* Damon Runyon Cancer Research Foundation, New York
* Phllip L. Drosnes and the Drosnes-Lazenbey Clinic, Pittsburgh, Pa.
* Dr. F. M. Eugene, Blass Clinic, Long Valley, New Jersey
* Dr. Gregory Clinic, Pasadena, California
* Hoxsey Cancer Clinic, 4507 Gaston Avenue, Dallas, Texas
* C. P. Huntington Fund, New York
* International Cancer Research Foundation, Philadelphia, Pa.
* Johns Hopkins Hospital, Baltimore, Md.
* Dr. Waldo Jones, Myrtle Beach, South Carolina
* Lakeland Foundation, Chicago, Illinois
* Lincoln Foundation, Medford, Mass.
* Memorial Hospital, New York
* Dr. K. F. Murphy and Dr. Charles Lyman Lofler Clinic, 25 E. Washington Street, Chicago, Illinois
* New York Skin and Cancer Hospital, New York
* Radium Institute of New York
* Henry Rutherford Fund, New York
* Charles F. Spang Foundation, Pittsburgh, Pa.
* University of Chicago, Chicago, Illinois
* University of Illinois, Champaign, Illinois
Government Organizations:
* The Department of Health, Education and Welfare
** Food and Drug Administration
** Federal Trade Commission
As Fitzgerald states in the opening paragraphs of his report, his studies were conducted to examine the following:

"1. All those individuals, organizations, foundations, hospitals and clinics, throughout the United States, which have an effect upon interstate commerce and which have been conducting researches, investigations, experiments and demonstrations relating to the cause, prevention, and methods of diagnosis and treatment of the disease cancer, to determine the interstate ramifications of their operations, their financial structures, including their fund-raising methods, and the amounts expended for clinical research as distinguished from administrative expenditures, and to ascertain the extent of the therapeutic value claimed by each in the use of its particular therapy.
2. The facts involving the discovery of, the imports from a foreign country of, the researches upon, and the interstate experiments, demonstrations, and use of the various drugs, preparations, and remedies for the treatment of the disease cancer, such drugs to include the so-called wonder drug Krebiozen, Glyoxylide, Mucorhicin and others.
3. The facts involving the interstate conspiracy, if any, engaged in by any individuals, organizations, corporations, associations, and combines of any kind whatsoever, to hinder, suppress, or restrict the free flow or transmission of Krebiozen, Glyoxylide, and Mucorhicin, and other drugs, preparations and remedies, and information, researches, investigations, experiments and demonstrations relating to the cause, prevention and methods of diagnosis and treatment of the disease cancer.
4. The facts involving the operations of voluntary cooperative prepaid medical plans and the organizations sponsoring said plans which are engaged in interstate commerce and which include in their programs medical treatment for the disease cancer, to determine the extent of their interstate insurance operations, the identity of their originators and sponsors, and the resistance, if any, that each insurer has experienced from any individuals, organizations, corporations, associations, or combines, in their attempts to offer protection to those who are afflicted with the disease cancer.
5. The facts involving the inequality of opportunity, if any, that exists with regard to race, creed or color, in connection with the admission of students, researchers, and patients to institutions throughout the United States engaged in cancer therapy.". The report was submitted into the Congressional Record Appendix August 3, 1953 where it has remained until it was recently unearthed by Dr. Stanley Monteith.<ref name=Gupta/>

Main Menu

See Also

Main Menu